Heller Bridgette P 4
4 · DEXCOM INC · Filed Feb 17, 2026
Research Summary
AI-generated summary of this filing
Dexcom (DXCM) Director Bridgette Heller Sells 1,012 Shares
What Happened
Bridgette P. Heller, a director of Dexcom, sold 1,012 shares on February 12, 2026 at $68.01 per share, for proceeds of $68,826. The filing indicates the shares were disposed pursuant to a 10b5-1 trading plan adopted by Ms. Heller on August 14, 2025. This was a sale (not a purchase), which is commonly a routine disposition rather than a direct signal of changed sentiment.
Key Details
- Transaction date and price: 2026-02-12 — 1,012 shares sold at $68.01 each (total $68,826).
- Sale type/code: Open-market sale (reported as "S"); executed under a pre-established 10b5-1 plan (see footnote).
- Filing date: Form 4 filed 2026-02-17. (Filed within typical SEC reporting timeframe.)
- Shares owned after transaction: Not specified in the provided excerpt.
- Notable footnotes:
- F1: 10b5-1 plan adopted Aug 14, 2025; the sale was made pursuant to that plan.
- F2: The filing notes 5,046 unvested restricted stock units granted May 8, 2025 that vest by the earlier of the one-year anniversary of the grant or Dexcom’s 2026 Annual Meeting.
Context
Sales executed under 10b5-1 plans are pre-scheduled and often reflect planned diversification or liquidity needs; they are less informative about an insider’s current view of the company than new, unscheduled purchases. No options exercise, gift, or tax-withholding transaction was reported in this filing excerpt.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-02-12$68.01/sh−1,012$68,826→ 26,019 total
Footnotes (2)
- [F1]On August 14, 2025, Ms. Heller adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Heller. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- [F2]Included in this number are 5,046 unvested restricted stock units which were granted on May 8, 2025 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders.